Frontiers in Molecular Biosciences | Molecular Diagnostics and Therapeutics

Editorial

Published on 22 Jun 2023

Editorial: Cancer treatment and early detection targeting HER receptors, Volume II

in Molecular Diagnostics and Therapeutics

Xiaoqing Cai
Libing Zhang
Shengxi Chen

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1229765

1,722 views
1 citation

Original Research

Published on 20 Jun 2023

Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer

in Molecular Diagnostics and Therapeutics

Lianfang Zhao
Yuqin Tang
Jiayan Yang
Fang Lin
Xiaofang Liu
Yongqiang Zhang
Jianhui Chen

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1208132

5,230 views
4 citations

Original Research

Published on 20 Jun 2023

Molecular and biochemical investigations of the anti-fatigue effects of tea polyphenols and fruit extracts of Lycium ruthenicum Murr. on mice with exercise-induced fatigue

in Molecular Diagnostics and Therapeutics

Yingxin Bi
Xianjun Liu
Yue Liu
Mengyuan Wang
Yaming Shan
Yuhe Yin
Xianglong Meng
Fengjie Sun
Hao Li
Zhandong Li

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1223411

3,689 views
5 citations

Review

Published on 19 Jun 2023

Psoriasis immunometabolism: progress on metabolic biomarkers and targeted therapy

in Molecular Diagnostics and Therapeutics

Evangelia Sarandi
Sabine Krueger-Krasagakis
Dimitris Tsoukalas
Polytimi Sidiropoulou
George Evangelou
Maria Sifaki
Gottfried Rudofsky
Nikolaos Drakoulis
Aristidis Tsatsakis

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1201912

8,905 views
14 citations

Review

Published on 14 Jun 2023

Radiotherapy-induced ferroptosis for cancer treatment

in Molecular Diagnostics and Therapeutics

Giovanni L. Beretta
Nadia Zaffaroni

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1216733

5,518 views
20 citations

Original Research

Published on 14 Jun 2023

RelB is a potential molecular biomarker for immunotherapy in human pan-cancer

in Molecular Diagnostics and Therapeutics

Jintao Wu
Xinyu Yu
Hongyu Zhu
Peng Chen
Tongyan Liu
Rong Yin
Yan Qiang
Lin Xu

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1178446

3,644 views
4 citations

Original Research

Published on 14 Jun 2023

An artificial intelligence prediction model based on extracellular matrix proteins for the prognostic prediction and immunotherapeutic evaluation of ovarian serous adenocarcinoma

in Molecular Diagnostics and Therapeutics

Tianxiang Geng
Mengxue Zheng
Yongfeng Wang
Janne Elin Reseland
Athina Samara

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1200354

4,601 views
4 citations

Original Research

Published on 14 Jun 2023

The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro-tumor genes VEGF and PDL1 expression in the 4T1/Balb/c mouse model of stage four breast cancer

in Molecular Diagnostics and Therapeutics

Rafiq Nabi
Farhana Musarrat
Jose Cesar Menk P. Lima
Ingeborg M. Langohr
Vladimir N. Chouljenko
Konstantin G. Kousoulas

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1199068

5,792 views
7 citations

Editorial

Published on 14 Jun 2023

Editorial: Heterogeneity and plasticity of prostate cancer

in Molecular Diagnostics and Therapeutics

Zoran Culig
Mohit Kumar Jolly
Karel Souček

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1228126

2,445 views

Original Research

Published on 09 Jun 2023

Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes

in Molecular Diagnostics and Therapeutics

Xin Huang
Chongyu Zhao
Yuanxia Han
Shengping Li

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1143073

2,477 views
1 citation

Original Research

Published on 09 Jun 2023

Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods

in Molecular Diagnostics and Therapeutics

Ruishan Wu
Cailin Wu
Bingming Zhu
Jin Li
Wenzhong Zhao

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1192313

3,166 views
4 citations

Original Research

Published on 09 Jun 2023

Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia

in Molecular Diagnostics and Therapeutics

Clara Vicente-Garcés
Joan Maynou
Guerau Fernández
Elena Esperanza-Cebollada
Montserrat Torrebadell
Albert Català
Susana Rives
Mireia Camós
Nerea Vega-García

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1141310

5,522 views
7 citations

Original Research

Published on 08 Jun 2023

Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples

in Molecular Diagnostics and Therapeutics

Olga S. Kolovskaya
Alena V. Zyuzyukina
Justin P. Dassie
Galina S. Zamay
Tatiana N. Zamay
Nina V. Boyakova
Vladimir A. Khorzhevskii
Daria A. Kirichenko
Ivan N. Lapin
Irina A. Shchugoreva

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1184285

4,140 views
6 citations

Original Research

Published on 07 Jun 2023

Multi-omic analysis of glycolytic signatures: exploring the predictive significance of heterogeneity and stemness in immunotherapy response and outcomes in hepatocellular carcinoma

in Molecular Diagnostics and Therapeutics

Shiyu Zhang
Yangting Pei
Feng Zhu

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1210111

2,488 views
2 citations

Editorial

Published on 06 Jun 2023

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers

in Molecular Diagnostics and Therapeutics

Chenxi Cao
Shuang Chen
Libo Wang
Zaoqu Liu
Xinwei Han

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1190116

2,543 views

Original Research

Published on 02 Jun 2023

Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach

in Molecular Diagnostics and Therapeutics

Geovanny Genaro Reivan Ortiz
Carmen Iulia Ciongradi
M. V. N. L. Chaitanya
Jayasankar Narayanan
Mohamed Mohany
Salim S. Al-Rejaie
José Luis Arias-Gonzáles
Ioan Sârbu
Marjan Assefi
Shaik Vaseem Akram

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1189527

4,728 views
3 citations

Navigation group

Articles

Editorial: Cancer treatment and early detection targeting HER receptors, Volume II

Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer

Molecular and biochemical investigations of the anti-fatigue effects of tea polyphenols and fruit extracts of Lycium ruthenicum Murr. on mice with exercise-induced fatigue

Psoriasis immunometabolism: progress on metabolic biomarkers and targeted therapy

Radiotherapy-induced ferroptosis for cancer treatment

RelB is a potential molecular biomarker for immunotherapy in human pan-cancer

An artificial intelligence prediction model based on extracellular matrix proteins for the prognostic prediction and immunotherapeutic evaluation of ovarian serous adenocarcinoma

The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro-tumor genes VEGF and PDL1 expression in the 4T1/Balb/c mouse model of stage four breast cancer

Editorial: Heterogeneity and plasticity of prostate cancer

Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes

Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods

Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia

Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples

Multi-omic analysis of glycolytic signatures: exploring the predictive significance of heterogeneity and stemness in immunotherapy response and outcomes in hepatocellular carcinoma

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers

Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach